We are live on
!
Find out more
Aristotle Capital Management Portfolio holdings
AUM
$47.7B
1-Year Est. Return
13.92%
This Fund
S&P 500
This Quarter
Est. Return
+8.77%
1 Year Est. Return
+13.92%
3 Year Est. Return
+50.48%
5 Year Est. Return
+59.96%
10 Year Est. Return
+301.3%
AUM
$6.29B
AUM Growth
+$1.29B
(+26%)
Cap. Flow
+$843M
Cap. Flow
% of AUM
13.4%
Top 10 Holdings %
Top 10 Hldgs %
28.63%
Holding
141
New
7
Increased
80
Reduced
15
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oshkosh
OSK
|
+$127M |
| 2 |
Banco Santander
SAN
|
+$52.3M |
| 3 |
AbbVie
ABBV
|
+$36.1M |
| 4 |
Diageo
DEO
|
+$30.9M |
| 5 |
UN
Unilever NV New York Registry Shares
UN
|
+$27.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bunge Global
BG
|
+$98.9M |
| 2 |
Vodafone
VOD
|
+$88.1M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$6.96M |
| 4 |
Lumen
LUMN
|
+$6.42M |
| 5 |
Willis Towers Watson
WTW
|
+$3.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.98% |
| 2 | Technology | 13.73% |
| 3 | Consumer Discretionary | 12.95% |
| 4 | Healthcare | 11.99% |
| 5 | Industrials | 11.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ROSE
126
DELISTED
ROSETTA RESOURCES INC
ROSE
| $288K | ﹤0.01% |
6,000
| – | – |
|
127
Becton Dickinson
BDX
$49.8B
| $276K | ﹤0.01% |
+2,563
| New | +$266K |
|
|
POT
128
DELISTED
Potash Corp Of Saskatchewan
POT
| $261K | ﹤0.01% |
+7,930
| New | +$253K |
|
129
Air Products & Chemicals
APD
$63.9B
| $257K | ﹤0.01% |
+2,486
| New | +$251K |
|
130
Costco
COST
$408B
| $233K | ﹤0.01% |
1,955
-1,000
| -34% | -$120K |
|
131
Gilead Sciences
GILD
$182B
| $227K | ﹤0.01% |
+3,025
| New | +$211K |
|
132
AT&T
T
$182B
| $221K | ﹤0.01% |
8,308
| – | – |
|
|
MJN
133
DELISTED
Mead Johnson Nutrition Company
MJN
| $216K | ﹤0.01% |
+2,584
| New | +$210K |
|
134
Western Union
WU
$2.19B
| $173K | ﹤0.01% |
10,000
| – | – |
|
|
135
Lumen
LUMN
$7.25B
| – | – |
-204,700
| Closed | -$6.42M |
|
136
Nike
NKE
$55B
| – | – |
-10,400
| Closed | -$378K |
|
137
Teva Pharmaceuticals
TEVA
$45.1B
| – | – |
-88,268
| Closed | -$3.33M |
|
|
138
Vodafone
VOD
$40.6B
| – | – |
-2,455,805
| Closed | -$88.1M |
|
|
139
Willis Towers Watson
WTW
$30.1B
| – | – |
-31,906
| Closed | -$3.66M |
|
|
MNK
140
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-157,903
| Closed | -$6.96M |
|
Similar funds
SCP
VCMC
EP
Aristotle Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Aristotle Capital Management held 141 positions worth $6.29B, up 26% from $4.99B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Aristotle Capital Management deployed $843M of net new capital in Q4 2013, opening 7 new positions and adding to 80 existing holdings. Its largest new stake was Oshkosh: 2,543,807 shares worth $128M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bunge Global, an estimated $98.9M trimmed.
- Aristotle Capital Management's largest Q4 2013 buy was Oshkosh: 2,543,807 shares worth $128M.
- Aristotle Capital Management added most to Banco Santander in Q4 2013, an estimated $52.3M increase.
- Aristotle Capital Management's biggest Q4 2013 reduction was Bunge Global, cutting an estimated $98.9M.
- Aristotle Capital Management fully exited Vodafone in Q4 2013, selling an estimated $88.1M.
- Aristotle Capital Management's ten largest holdings make up 29% of its $6.29B portfolio in Q4 2013.
- Aristotle Capital Management opened 7 new positions and closed 6 in Q4 2013.
- Aristotle Capital Management's portfolio value rose 26% quarter-over-quarter to $6.29B.
Based on Aristotle Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.